BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6169867)

  • 41. [Studies on stimulation of immunological responses resulting from intravesical BCG instillation in patients with bladder carcinomas].
    Tachibana M; Jitsukawa S; Deguchi N; Tazaki H
    Nihon Hinyokika Gakkai Zasshi; 1988 Oct; 79(10):1680-5. PubMed ID: 3251104
    [No Abstract]   [Full Text] [Related]  

  • 42. Carcinoembryonic antigen (CEA) in plasma of patients with carcinoma of the bladder/urethra.
    Orjasaeter H; Fosså SD; Schjølseth SA; Fjaestad K
    Cancer; 1978 Jul; 42(1):287-95. PubMed ID: 667800
    [No Abstract]   [Full Text] [Related]  

  • 43. Predicting bacillus Calmette-Guerin immunotherapy effectiveness.
    Griffith TS
    J Urol; 2007 Dec; 178(6):2247-8. PubMed ID: 17936825
    [No Abstract]   [Full Text] [Related]  

  • 44. [A hyperthermic perfusion therapy using peplomycin and ethanol for bladder cancer].
    Nakajima K; Hisazumi H; Misaki T; Kawaguchi K; Sugata T; Kameda K; Ueki O; Miyagi T; Nishino A
    Hinyokika Kiyo; 1984 Oct; 30(10):1421-6. PubMed ID: 6084417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natural killer (NK) cell assay within bladder mucosa of patients bearing transitional cell carcinoma (TCC) after interferon (IFN) therapy: an immunohistochemical and ultrastructural study.
    Natsis K; Toliou T; Stravoravdi P; Kirtsis P; Grekou A; Barich A; Konstantinidis E; Gigis P
    Int J Clin Pharmacol Res; 1997; 17(1):31-6. PubMed ID: 9403351
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hyperthermic treatment with peplomycin and bestatin in superficial bladder cancer].
    Kitagawa M; Ushiyama T; Suzuki K; Tajima A; Aso Y
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1820-6. PubMed ID: 2412496
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peripheral blood lymphocyte response in patients with superficial transitional cell carcinoma of the bladder treated with intravesical Bacillus Calmette-Guérin--a useful marker of response?
    Schmidt AC; Bouic PJ; Heyns CF; De Kock ML
    Br J Urol; 1993 Feb; 71(2):179-82. PubMed ID: 8461951
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of peripheral blood T-cell subpopulation of bladder cancer patients.
    Greenstein A; Pecht M; Kaver I; Trainin N; Braf Z
    Urol Res; 1991; 19(4):219-22. PubMed ID: 1926656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Experimental studies on effects of carcinostatic agents (author's transl)].
    Yokota T; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1975 May; 66(5):249-53. PubMed ID: 50470
    [No Abstract]   [Full Text] [Related]  

  • 50. Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors.
    Morales A; Eidinger D; Bruce AW
    J Urol; 1976 Aug; 116(2):180-3. PubMed ID: 820877
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyperthermia in the treatment of bladder tumours.
    Hall RR; Wadehra V; Towler JM; Hindmarsh JR; Byrne PO
    Br J Urol; 1976; 48(7):603-8. PubMed ID: 1016833
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Immunotherapy of superficial bladder cancer].
    Schmitz-Dräger BJ; Schattka SO; Ebert T
    Urologe A; 1993 Sep; 32(5):374-81. PubMed ID: 8212422
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is the success of BCG tumour immunotherapy due to the induction of co-stimulatory molecules?
    Alexandroff AB; Mitchell I; Black J; James K
    Biochem Soc Trans; 1997 May; 25(2):201S. PubMed ID: 9191245
    [No Abstract]   [Full Text] [Related]  

  • 54. [Immunofluorescence study of the distribution of ABH cell surface antigens in bladder tumours (author's transl)].
    Vallancien G; Rouger P; Leclerc JP; Kuss R
    Sem Hop; 1982 May; 58(19):1161-4. PubMed ID: 6285497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors.
    Morales A; Eidinger D; Bruce AW
    J Urol; 2017 Feb; 197(2S):S142-S145. PubMed ID: 28012770
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transfer of adoptive immunity by intra-arterial injection of tumor-immune pig lymph node cells: treatment of recurrent urinary bladder carcinoma after radical radiotherapy.
    Symes MO; Mitchell JP; Eckert H; Roberts JB; Feneley RC; Tribe CR; Lai T
    Urology; 1978 Oct; 12(4):398-401. PubMed ID: 715964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune response in bladder cancer.
    Merrin C; Han T
    J Urol; 1974 Feb; 111(2):170-2. PubMed ID: 4810757
    [No Abstract]   [Full Text] [Related]  

  • 58. [Results of local transurethral high frequency hyperthermia in bladder carcinoma (author's transl)].
    Bichler KH; Harzmann R; Flachenecker G; Fastenmeier K; Altenähr E; Gericke D; Flüchter SH
    Urologe A; 1982 Jan; 21(1):12-9. PubMed ID: 7200652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preliminary report of the use of levamisole in the treatment of bladder cancer.
    Smith RB; deKernion J; Lincoln B; Skinner DG; Kaufman JJ
    Cancer Treat Rep; 1978 Nov; 62(11):1709-14. PubMed ID: 365325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperthermic irrigation of urinary bladder tumor in rabbits.
    Nemoto R; Kato T; Mori H; Iwata K; Harada M
    Tohoku J Exp Med; 1982 Jun; 137(2):199-205. PubMed ID: 7112544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.